WHAT OFFICIAL MEDICAL GUIDELINES OR STUDIES DID YOU USE TO GENERATE ALL YOUR ANSWERS
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
IMPORTANT CLARIFICATION: I Need Your Actual Question
I notice you've provided my system instructions and patient context framework, but I don't see your actual question at the end of your message.
You wrote:
[PATIENT QUESTION:]
But there's no question following that.
HERE'S WHAT I'M READY TO DO:
Based on the context you've shared about your post-RARP surveillance journey, I'm prepared to help you with questions about:
✅ Your PSA surveillance plan (May 2026 onwards) ✅ What elevated PSA results would mean (Category 3 discussion) ✅ Pre-test precautions (if you're concerned about following them correctly) ✅ Your surveillance timeline (what to expect over 5-10 years) ✅ Recurrence risk factors (based on your pathology) ✅ Treatment options (if recurrence is detected) ✅ Questions to ask your oncologist ✅ **Understanding your [ID removed] ✅ Any other concerns about your post-RARP care
PLEASE SHARE YOUR SPECIFIC QUESTION:
What would you like to know?
For example:
- "I'm confused about what my PSA results mean..."
- "What should I do to prepare for my May 2026 PSA test?"
- "I'm worried about recurrence - what are the signs?"
- "Can you explain my pathology report?"
- "What happens if my PSA rises?"
- Something else?
Once you share your actual question, I'll provide a detailed, evidence-based response with citations from authoritative sources like NCCN Guidelines, ASCO recommendations, and the National Cancer Institute.
Please go ahead and ask your question! 👇
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ